Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Peter Joosten
Observed names:
P Joosten,
P. Joosten
Institution:
Medisch Centrum Leeuwarden
Observed institutions:
Leiden University Medical Center,
Hammersmith Hospital,
Medisch Centrum Leeuwarden,
University Medical Center Utrecht,
Hovon
OpenAlex ID:
A5110068950
A randomized phase 3 study on the effect of thalidomide combined with adriamycin, dexamethasone, and high-dose melphalan, followed by thalidomide maintenance in patients with multiple myeloma
2009
·
Henk M. Lokhorst
, Bronno van der Holt
, et al.
·
Blood
·
277
PDF
Complete Remission of Accelerated Phase Chronic Myeloid Leukemia by Treatment With Leukemia-Reactive Cytotoxic T Lymphocytes
1999
·
J.H. Frederik Falkenburg
, Amon R. Wafelman
, et al.
·
Blood
·
264
Thalidomide in induction treatment increases the very good partial response rate before and after high-dose therapy in previously untreated multiple myeloma
2007
·
H. M. Lokhorst
, I. Schmidt-Wolf
, et al.
·
Haematologica
·
142
PDF
Comorbidity is an independent prognostic factor in patients with advanced-stage diffuse large B-cell lymphoma treated with R-CHOP: a population-based cohort study
2014
·
Andre Wieringa
, Karin Boslooper
, et al.
·
British Journal of Haematology
·
82
Quality of life of patients with chronic lymphocytic leukaemia in the Netherlands: results of a longitudinal multicentre study
2015
·
K. M. Holtzer-Goor
, M. R. Schaafsma
, et al.
·
Quality of Life Research
·
55
PDF
Treatment with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone is beneficial but toxic in very elderly patients with diffuse large B-cell lymphoma: a population-based cohort study on treatment, toxicity and outcome
2013
·
Karin Boslooper
, Robby Kibbelaar
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
51
Bridging the gap between the randomised clinical trial world and the real world by combination of population-based registry and electronic health record data: A case study in haemato-oncology
2017
·
R.E. Kibbelaar
, B.E. Oortgiesen
, et al.
·
European Journal of Cancer
·
43
PDF
Induction therapy with vincristine, adriamycin, dexamethasone (VAD) and intermediate-dose melphalan (IDM) followed by autologous or allogeneic stem cell transplantation in newly diagnosed multiple myeloma
1999
·
HM Lokhorst
, P Sonneveld
, et al.
·
Bone Marrow Transplantation
·
34
Adequate Sampling in Cryoglobulinaemia: Recommended Warmly
2003
·
Andries J. Bakker
, Jennichjen Slomp
, et al.
·
Clinical Chemistry and Laboratory Medicine (CCLM)
·
19
Pancytopenia related eosinophilia in rheumatoid arthritis: a specific methotrexate phenomenon?
1995
·
G A Bruyn
, E Velthuysen
, et al.
·
PubMed
·
18
Cost‐effectiveness of rituximab as maintenance treatment for relapsed follicular lymphoma: results of a population‐based study
2014
·
Hedwig M. Blommestein
, Djamila E. Issa
, et al.
·
European Journal Of Haematology
·
17
Relapse in stage I(E) diffuse large B‐cell lymphoma
2017
·
Marcel Nijland
, Karin Boslooper
, et al.
·
Hematological Oncology
·
16
PDF
Enteropathy-associated T-cell lymphoma presenting with eosinophilia.
2003
·
S Hovenga
, H de Graaf
, et al.
·
PubMed
·
11
Real-world costs of chronic lymphocytic leukaemia in the Netherlands
2013
·
K.M. Holtzer-Goor
, C.A.M. Bouwmans-Frijters
, et al.
·
Leukemia Research
·
10
Nafazatrom in Treatment of Thrombotic Thrombocytopenic Purpura
1985
·
S.T.S. Durrant
, P. Joosten
, et al.
·
The Lancet
·
8
The role of initial clinical presentation, comorbidity and treatment in multiple myeloma patients on survival: a detailed population-based cohort study
2017
·
B. E. Oortgiesen
, E.N. van Roon
, et al.
·
European Journal of Clinical Pharmacology
·
7
PDF
Thalidomide Combined With High Dose Melphalan Improves Event Free and Overall Survival In Patients With Newly Diagnosed Multiple Myeloma: Extended Follow-Up Of The HOVON-50 Trial
2013
·
Henk Lokhorst
, Bronno van der Holt
, et al.
·
Blood
·
2
HemoBase: A Multidisciplinary Registration Systeem in Hemato-Oncology.
2006
·
Peter Joosten
, Mels Hoogendoorn
, et al.
·
Blood
·
2
Overall Survival Patterns in Patients with Multiple Myeloma in the Era of Novel Agents and the Role of Initial Clinical Presentation and Comorbidities: A Population-Based Study
2014
·
Berdien Oortgiesen
, Eric N. van Roon
, et al.
·
Blood
·
1
Influence of Prophylactic Platelet Transfusions on the Recovery of Bone Marrow Function After Intensive Chemotherapy for Acute Myeloid Leukemia.
2010
·
Roland MH Kivit
, Peter Joosten
, et al.
·
Blood
·
1
Unsuccessful Treatment with Lenalidomide in a Diamond-Blackfan Anemia Patient.
2009
·
Peter Joosten
, Mels Hoogendoorn
, et al.
·
Blood
·
1
Impact of Radiotherapy and Rituximab on Outcome of Stage I(E) Diffuse Large B-Cell Lymphoma
2015
·
Marcel Nijland
, Karin Boslooper
, et al.
·
Blood
Prognostic Importance of Comorbidity in a Population-Based Analysis of Patients with Advanced-Stage Diffuse Large B-Cell Lymphoma (DLBCL) Treated with R-CHOP
2012
·
André Wieringa
, Eric N. van Roon
, et al.
·
Blood
A Significant Better Two Year Survival in the Very Elderly Patients with a Diffuse Large B-Cell Lymphoma (DLBCL) Who Did Complete Standard Therapy: A Population-Based Cohort Study On Treatment, Toxicity and Outcome.
2012
·
Karin Boslooper
, Peter Joosten
, et al.
·
Blood
Cost-Effectiveness of Rituximab As Maintenance Treatment for Relapsed Follicular Lymphoma: Results of a Population Based Study
2012
·
Hedwig M Blommestein
, Djamila E Issa
, et al.
·
Blood
Show more works
View as search
Works count:
27
Citation count:
1,061
H-index:
12
I10-index:
14
Year
Topic
Type